Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-Coding RNAs in COVID-19: Emerging Insights and Current Questions
Tobias Plowman, Dimitris Lagos
Non-Coding RNA (2021) Vol. 7, Iss. 3, pp. 54-54
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Non-coding RNAs in human health and disease: potential function as biomarkers and therapeutic targets
Tamizhini Loganathan, C. George Priya Doss
Functional & Integrative Genomics (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 93
Long non-coding RNAs (lncRNAs) NEAT1 and MALAT1 are differentially expressed in severe COVID-19 patients: An integrated single-cell analysis
Huang Kai, Catherine Wang, Christen Vagts, et al.
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0261242-e0261242
Open Access | Times Cited: 62
The expression patterns of MALAT-1, NEAT-1, THRIL, and miR-155-5p in the acute to the post-acute phase of COVID-19 disease
Mohammad Abbasi‐Kolli, Javid Sadri Nahand, Seyed Jalal Kiani, et al.
The Brazilian Journal of Infectious Diseases (2022) Vol. 26, Iss. 3, pp. 102354-102354
Open Access | Times Cited: 44
Exosomal miR-145 and miR-885 Regulate Thrombosis in COVID-19
Jessica Gambardella, Urna Kansakar, Celestino Sardu, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 109-115
Open Access | Times Cited: 38
Integrated miRNA/cytokine/chemokine profiling reveals severity-associated step changes and principal correlates of fatality in COVID-19
Julie Wilson, David Kealy, Sally James, et al.
iScience (2021) Vol. 25, Iss. 1, pp. 103672-103672
Open Access | Times Cited: 37
Cardiovascular Implications of microRNAs in Coronavirus Disease 2019
Carmine Izzo, Valeria Visco, Jessica Gambardella, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 102-108
Open Access | Times Cited: 21
Interplay of LncRNAs NEAT1 and TUG1 in Incidence of Cytokine Storm in Appraisal of COVID-19 Infection
Safaa I. Tayel, Eman A. El-Masry, Gehan A. Abdelaal, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 13, pp. 4901-4913
Open Access | Times Cited: 20
In silico identification of potential miRNAs -mRNA inflammatory networks implicated in the pathogenesis of COVID-19
Somayeh Hashemi Sheikhshabani, Zeinab Amini‐Farsani, Parastoo Modarres, et al.
Human Gene (2023) Vol. 36, pp. 201172-201172
Open Access | Times Cited: 9
Evaluation of long non-coding RNAs EGOT, NRAV, NRIR and mRNAs ISG15 and IFITM3 expressions in COVID-19 patients
Zahra Sefatjoo, Seyed Reza Mohebbi, Seyed Masoud Hosseini, et al.
Cytokine (2024) Vol. 175, pp. 156495-156495
Closed Access | Times Cited: 3
Exosomes, and the potential for exosome‐based interventions against COVID‐19
Abolfazl Rahmani, Ali Soleymani, Mustafa Almukhtar, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 4
Closed Access | Times Cited: 3
Non-coding RNAs and their bioengineering applications for neurological diseases
Tuhin Das, Tushar Kanti Das, Anne Khodarkovskaya, et al.
Bioengineered (2021) Vol. 12, Iss. 2, pp. 11675-11698
Open Access | Times Cited: 21
Downregulation of MALAT1 is a hallmark of tissue and peripheral proliferative T cells in COVID-19
Shoumit Dey, Helen Ashwin, Luke Milross, et al.
Clinical & Experimental Immunology (2023) Vol. 212, Iss. 3, pp. 262-275
Open Access | Times Cited: 9
Tangled quest of post-COVID-19 infection-caused neuropathology and what 3P nano-bio-medicine can solve?
Nadia Μ. Hamdy, Fatma H. Shaker, Xianquan Zhan, et al.
The EPMA Journal (2022) Vol. 13, Iss. 2, pp. 261-284
Open Access | Times Cited: 13
Computational identification of differentially-expressed genes as suggested novel COVID-19 biomarkers: A bioinformatics analysis of expression profiles
Valentina Di Salvatore, Elena Crispino, Avisa Maleki, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 3339-3354
Open Access | Times Cited: 7
The SARS-CoV-2 protein NSP2 enhances microRNA-mediated translational repression
Parisa Naeli, Xu Zhang, Patric Harris Snell, et al.
Journal of Cell Science (2023) Vol. 136, Iss. 19
Open Access | Times Cited: 7
The relationship between microRNAs and COVID-19 complications
Abdollah Kebriaei, Reza Besharati, Hasan Namdar Ahmad Abad, et al.
Non-coding RNA Research (2024) Vol. 10, pp. 16-24
Open Access | Times Cited: 2
Host nasopharyngeal transcriptome dataset of a SARS-CoV-2 positive Italian cohort
Annamaria Salvati, Carlo Ferravante, Jessica Lamberti, et al.
Scientific Data (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Non-coding RNA in idiopathic interstitial pneumonia and Covid-19 pulmonary fibrosis
Mohammad Shadab Ali, Jay Singh, Md Tanjim Alam, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 12, pp. 11535-11546
Open Access | Times Cited: 7
Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm
Mai Abdel Haleem Abusalah, Moad Khalifa, Mohammad A. I. Al-Hatamleh, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 3, pp. 386-386
Open Access | Times Cited: 6
Expression patterns of lncRNA MALAT-1 in SARS-COV-2 infection and its potential effect on disease severity via miR-200c-3p and SIRT1
Olfat Shaker, Monica El Amir, Yasmine Abd Elfatah, et al.
Biochemistry and Biophysics Reports (2023) Vol. 36, pp. 101562-101562
Open Access | Times Cited: 3
Host tRNA-Derived RNAs Target the 3′Untranslated Region of SARS-CoV-2
Emily N. Hendrickson, Marna E. Ericson, Lynne Bemis
Pathogens (2022) Vol. 11, Iss. 12, pp. 1479-1479
Open Access | Times Cited: 4
Insights into Cardiovascular Defects and Cardiac Epigenome in the Context of COVID-19
Shreya Sarkar, Rwik Sen
Epigenomes (2022) Vol. 6, Iss. 2, pp. 13-13
Open Access | Times Cited: 3
SARS-CoV-2 protein NSP2 enhances microRNA-mediated translational repression
Parisa Naeli, Xu Zhang, Patric Harris Snell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
The Anti-Viral Activity of Stem Cells: A Rational Explanation for their Use in Clinical Application
Mario Giosuè Balzanelli, Pietro Distratis, Rita Lazzaro, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2022) Vol. 23, Iss. 6, pp. 739-747
Closed Access | Times Cited: 2
Unpacking COVID-19 Systems Biology in Lung and Whole Blood with Transcriptomics and miRNA Regulators
Dimitra Anatolou, Nikolas Dovrolis, Georgia Ragia, et al.
OMICS A Journal of Integrative Biology (2022) Vol. 26, Iss. 11, pp. 608-621
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top